Hospital at Home for Elderly Acute Ill Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorDefactum, Central Denmark Region

About this trial

Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction.

Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated.

The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment.

This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.

Eligibility criteria

Qualifiers

The patient should be aged 65 and over

Diagnosed with a stable acute medical conditions e.g. cystitis, erysipelas, pneumonia

The patient should be living in their own home or a nursing home before entering the study

The patient should be residing in one of the three municipalities (Viborg, Skive and Silkeborg)

Disqualifiers

The patient is unable to give written consent

The capacity of the municipal acut team care was fully utilised.

Trial design

Treatments tested in this trial

  • Hospital at Home (HaH) treatment
  • Standard hospital admission

Treatment groups

849 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Defactum, Central Denmark Region

Lead sponsor

Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark

Collaborator

Research Center for Emergency Medicine, Aarhus University, Denmark

Collaborator

Viborg Regional Hospital

Collaborator